Andrew Guggenhime
Known title: President and CFOCIK: 0001230724
Associated companies
Transaction History
| PCVX | ▼ Sell | Tax Withholding | 7,155 | $432K | 9/8/2026 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 1,432 | $88K | 9/2/2026 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 1,273 | $77K | 8/31/2026 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 10,000 | $54K | 8/3/2026 | View on chart |
| PCVX | ▼ Sell | Open Market | 6,956 | $374K | 8/3/2026 | View on chart |
| PCVX | ▼ Sell | Open Market | 3,044 | $165K | 8/3/2026 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 10,000 | $54K | 7/6/2026 | View on chart |
| PCVX | ▼ Sell | Open Market | 7,913 | $452K | 7/6/2026 | View on chart |
| PCVX | ▼ Sell | Open Market | 2,087 | $121K | 7/6/2026 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 10,000 | $54K | 6/18/2026 | View on chart |
| PCVX | ▼ Sell | Open Market | 10,000 | $530K | 6/18/2026 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 1,021 | $61K | 3/9/2026 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 1,009 | $63K | 3/2/2026 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 898 | $56K | 2/28/2026 | View on chart |
| PCVX | ▲ Buy | Grant | 44,864 | $0 | 2/26/2026 | View on chart |
| PCVX | ▼ Sell | Gift | 61,850 | $0 | 1/14/2026 | View on chart |
| PCVX | ▼ Sell | Gift | 61,850 | $0 | 1/14/2026 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 2,890 | $94K | 9/8/2025 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 1,270 | $40K | 9/2/2025 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 2,381 | $75K | 9/2/2025 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 1,429 | $45K | 9/2/2025 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 4,777 | $100K | 4/7/2025 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 3,809 | $275K | 3/3/2025 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 1,270 | $93K | 2/28/2025 | View on chart |
| PCVX | ▲ Buy | Grant | 22,761 | $0 | 2/27/2025 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 8,000 | $43K | 2/18/2025 | View on chart |
| PCVX | ▼ Sell | Open Market | 6,182 | $517K | 2/18/2025 | View on chart |
| PCVX | ▼ Sell | Open Market | 1,818 | $154K | 2/18/2025 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 8,000 | $43K | 1/21/2025 | View on chart |
| PCVX | ▼ Sell | Open Market | 5,318 | $458K | 1/21/2025 | View on chart |
| PCVX | ▼ Sell | Open Market | 1,999 | $174K | 1/21/2025 | View on chart |
| PCVX | ▼ Sell | Open Market | 683 | $60K | 1/21/2025 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 8,000 | $43K | 12/18/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 1,190 | $104K | 12/18/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 3,373 | $299K | 12/18/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 3,157 | $282K | 12/18/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 280 | $25K | 12/18/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 132 | $11K | 11/18/2024 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 8,000 | $43K | 11/18/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 6,111 | $523K | 11/18/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 1,757 | $152K | 11/18/2024 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 19,108 | $400K | 10/25/2024 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 8,000 | $43K | 10/18/2024 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 8,000 | $43K | 10/18/2024 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 12,000 | $64K | 10/18/2024 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 14,000 | $75K | 10/18/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 36,114 | $4.2M | 10/18/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 5,886 | $684K | 10/18/2024 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 8,000 | $43K | 9/18/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 5,485 | $634K | 9/18/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 1,686 | $196K | 9/18/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 829 | $97K | 9/18/2024 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 6,337 | $698K | 9/3/2024 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 8,000 | $43K | 8/19/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 4,994 | $391K | 8/19/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 3,006 | $238K | 8/19/2024 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 8,000 | $43K | 7/18/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 3,095 | $248K | 7/18/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 2,500 | $203K | 7/18/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 1,479 | $122K | 7/18/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 926 | $77K | 7/18/2024 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 8,000 | $43K | 6/18/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 7,652 | $550K | 6/18/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 348 | $25K | 6/18/2024 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 8,000 | $43K | 5/20/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 3,544 | $264K | 5/20/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 4,456 | $336K | 5/20/2024 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 8,000 | $43K | 4/18/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 7,624 | $467K | 4/18/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 376 | $23K | 4/18/2024 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 8,000 | $43K | 3/18/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 7,764 | $536K | 3/18/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 236 | $16K | 3/18/2024 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 3,795 | $272K | 3/2/2024 | View on chart |
| PCVX | ▲ Buy | Grant | 20,000 | $0 | 2/29/2024 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 8,000 | $43K | 2/20/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 4,909 | $364K | 2/20/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 2,751 | $207K | 2/20/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 340 | $26K | 2/20/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 23 | $1K | 1/18/2024 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 8,000 | $43K | 1/18/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 4,387 | $264K | 1/18/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 3,127 | $191K | 1/18/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 463 | $29K | 1/18/2024 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 8,000 | $43K | 12/18/2023 | View on chart |
| PCVX | ▼ Sell | Open Market | 7,883 | $474K | 12/18/2023 | View on chart |
| PCVX | ▼ Sell | Open Market | 117 | $7K | 12/18/2023 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 14,000 | $75K | 12/14/2023 | View on chart |
| PCVX | ▼ Sell | Open Market | 14,000 | $843K | 12/14/2023 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 8,000 | $43K | 11/20/2023 | View on chart |
| PCVX | ▼ Sell | Open Market | 7,876 | $403K | 11/20/2023 | View on chart |
| PCVX | ▼ Sell | Open Market | 124 | $6K | 11/20/2023 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 8,000 | $43K | 10/18/2023 | View on chart |
| PCVX | ▼ Sell | Open Market | 7,497 | $344K | 10/18/2023 | View on chart |
| PCVX | ▼ Sell | Open Market | 503 | $23K | 10/18/2023 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 3,568 | $182K | 9/5/2023 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 1,727 | $72K | 3/2/2023 | View on chart |
| PCVX | ▲ Buy | Grant | 22,500 | $0 | 3/1/2023 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 23,691 | $127K | 12/30/2022 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 3,100 | $17K | 9/19/2022 | View on chart |
| PCVX | ▼ Sell | Open Market | 2,623 | $68K | 9/19/2022 | View on chart |
| PCVX | ▼ Sell | Open Market | 477 | $13K | 9/19/2022 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 4,649 | $123K | 9/2/2022 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 17,653 | $94K | 8/29/2022 | View on chart |
| PCVX | ▼ Sell | Open Market | 17,653 | $494K | 8/29/2022 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 1,295 | $7K | 8/26/2022 | View on chart |
| PCVX | ▼ Sell | Open Market | 1,295 | $36K | 8/26/2022 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 17,052 | $91K | 8/25/2022 | View on chart |
| PCVX | ▼ Sell | Open Market | 17,052 | $477K | 8/25/2022 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 3,100 | $17K | 8/18/2022 | View on chart |
| PCVX | ▼ Sell | Open Market | 2,551 | $64K | 8/18/2022 | View on chart |
| PCVX | ▼ Sell | Open Market | 549 | $14K | 8/18/2022 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 3,100 | $17K | 7/18/2022 | View on chart |
| PCVX | ▼ Sell | Open Market | 9 | $225 | 7/18/2022 | View on chart |
| PCVX | ▼ Sell | Open Market | 3,091 | $76K | 7/18/2022 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 3,100 | $17K | 7/8/2022 | View on chart |
| PCVX | ▼ Sell | Open Market | 3,100 | $74K | 7/8/2022 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 3,100 | $17K | 5/18/2022 | View on chart |
| PCVX | ▼ Sell | Open Market | 2,520 | $61K | 5/18/2022 | View on chart |
| PCVX | ▼ Sell | Open Market | 580 | $15K | 5/18/2022 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 3,100 | $17K | 4/18/2022 | View on chart |
| PCVX | ▼ Sell | Open Market | 3,100 | $75K | 4/18/2022 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 3,100 | $17K | 3/18/2022 | View on chart |
| PCVX | ▼ Sell | Open Market | 3,100 | $81K | 3/18/2022 | View on chart |
| PCVX | ▲ Buy | Grant | 37,500 | $0 | 3/2/2022 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 6,200 | $33K | 3/1/2022 | View on chart |
| PCVX | ▼ Sell | Open Market | 6,200 | $149K | 3/1/2022 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 3,100 | $17K | 12/23/2021 | View on chart |
| PCVX | ▼ Sell | Open Market | 3,100 | $74K | 12/23/2021 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 3,100 | $17K | 11/18/2021 | View on chart |
| PCVX | ▼ Sell | Open Market | 2,985 | $73K | 11/18/2021 | View on chart |
| PCVX | ▼ Sell | Open Market | 115 | $3K | 11/18/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
Vaxcyte VAX-31 clears Phase III OPUS-1 trial endpoints
Vaxcyte announced that its VAX-31 vaccine met all primary endpoints in the pivotal Phase III OPUS-1 trial. This positive data point positions the company for additional readouts expected in the first half of 2027. The stock is currently trading near its 52-week high, reflecting strong market interest in the clinical progress.
Vaxcyte VAX-31 clears Phase III OPUS-1 trial endpoints. Vaxcyte announced that its VAX-31 vaccine met all primary endpoints in the pivotal Phase III OPUS-1 trial. This positive data point positions the company for additional readouts expected in the first half of 2027. The stock is currently trading near its 52-week high, reflecting strong market interest in the clinical progress.